Dixon Richard A, Davidson Sean M, Wynne Abigail M, Yellon Derek M, Smith Christopher C T
The Hatter Cardiovascular Institute, University College London Hospital Medical School, London, United Kingdom.
J Cardiovasc Pharmacol. 2009 Apr;53(4):311-7. doi: 10.1097/FJC.0b013e31819d6152.
Protection against myocardial ischemia-reperfusion injury, including that induced by leptin, involves activation of the reperfusion injury salvage kinase pathway and inhibition of the mitochondrial permeability transition pore. In the current study, we explored the mechanisms underlying leptin-induced cardioprotection further with reference to the leptin receptor (OB-R) and obesity. We examined hearts from Wistar and Zucker lean rats that express functional OB-R and Zucker obese (fa/fa) rats with nonfunctional OB-R. In Langendorff experiments, leptin (10 nM) caused significant reductions in infarct size in hearts from Wistar (leptin treated, 32.4% +/- 3.9% vs. control, 53.2% +/- 3.2%, P < 0.01) and Zucker lean animals (leptin treated, 25.2% +/- 3.7% vs. control, 53.9% +/- 11.3%, P < 0.01). By contrast, hearts from (fa/fa) did not exhibit significant decreases in infarct size. Leptin increased p44 and p42 phosphorylation in Wistar rat hearts by 103.9% (P < 0.05) and 157.3% (P < 0.001), respectively, and by 97.0% (P < 0.05) and 158.1% (P < 0.05) in hearts from Zucker lean rats. Akt/serine-473 phosphorylation was increased in Wistar hearts by 96.7% (P < 0.05), whereas Akt/threonine-308 phosphorylation was elevated by 43.9% (P < 0.05) in Zucker lean rat hearts. Leptin did not influence Akt or p44/42 phosphorylation in (fa/fa) animals. On leptin treatment, mitochondrial permeability transition pore opening was delayed by 43% (P < 0.01) and 30.9% (P < 0.01), respectively, in cardiomyocytes from Wistar and Zucker lean rat hearts but not in cardiomyocytes from (fa/fa). This study provides the first evidence that myocardial sensitivity to the tissue preserving actions of leptin is influenced by adiposity and OB-R status.
对心肌缺血再灌注损伤的保护作用,包括由瘦素诱导的损伤,涉及再灌注损伤挽救激酶途径的激活和线粒体通透性转换孔的抑制。在本研究中,我们参照瘦素受体(OB-R)和肥胖情况进一步探究了瘦素诱导心脏保护作用的潜在机制。我们检测了表达功能性OB-R的Wistar大鼠和Zucker瘦大鼠以及OB-R无功能的Zucker肥胖(fa/fa)大鼠的心脏。在Langendorff实验中,瘦素(10 nM)使Wistar大鼠心脏(瘦素处理组梗死面积为32.4%±3.9%,对照组为53.2%±3.2%,P<0.01)和Zucker瘦大鼠心脏(瘦素处理组梗死面积为25.2%±3.7%,对照组为53.9%±11.3%,P<0.01)的梗死面积显著减小。相比之下, fa/fa大鼠心脏梗死面积未显著减小。瘦素使Wistar大鼠心脏中p44和p42的磷酸化分别增加103.9%(P<0.05)和157.3%(P<0.001),使Zucker瘦大鼠心脏中p44和p42的磷酸化分别增加97.0%(P<0.05)和158.1%(P<0.05)。Wistar大鼠心脏中Akt/丝氨酸-473磷酸化增加96.7%(P<0.05),而Zucker瘦大鼠心脏中Akt/苏氨酸-308磷酸化增加43.9%(P<于0.05)。瘦素对fa/fa大鼠的Akt或p44/42磷酸化无影响。瘦素处理后,Wistar大鼠和Zucker瘦大鼠心脏的心肌细胞线粒体通透性转换孔开放分别延迟43%(P<0.01)和30.9%(P<0.01),但fa/fa大鼠的心肌细胞未出现这种情况。本研究首次证明,心肌对瘦素组织保护作用的敏感性受肥胖程度和OB-R状态的影响。